ARTICLE | Company News
Intrexon, Genten deal
October 3, 2016 7:00 AM UTC
Intrexon granted newco Genten exclusive access to Intrexon’s ActoBiotics technology to deliver gluten peptide therapies to promote immune tolerance in patients with celiac disease. The ActoBiotics tec...